Prostatic Neoplasms: all 6,484 studies

Page 52 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.

• Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate CancerStatus unknownNCT01685125Phase 2
• Soy Isoflavones in Treating Patients With Recurrent Prostate Cancer or Rising Prostate-Specific AntigenCompletedNCT01682941Not applicable
• Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSACompletedNCT01681823Phase 2
• Impact of the Addition of Metformin to Abiraterone in Metastatic Prostate Cancer PatientsCompletedNCT01677897Phase 2
• Hypo-Fractionated Radiation Therapy for Localized Prostate CancerTerminatedNCT01677845Phase 1
• The Effect of Endurance Training on Body Composition and Insulin Sensitivity in Prostate Cancer Patients Receiving Androgen Deprivation TherapyCompletedNCT01676480Not applicable
• Degarelix Neo-Adjuvant Radical Prostatectomy TrialCompletedNCT01674270Phase 2
• Shared Decision Making in Low Risk Prostate CancerWithdrawnNCT01673581
• PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802CompletedNCT01672905
• Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates in the Diagnosis of Prostate CancerCompletedNCT01672411
• An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001CompletedNCT01664728Phase 1
• A Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate CancerWithdrawnNCT01663415Phase 2
• Vacuum Erection Device in Improving Recovery of Erectile Function in Patients With Prostate Cancer Undergoing SurgeryCompletedNCT01660152Not applicable
• TAK-700 in Castration Resistant Prostate CancerWithdrawnNCT01658527Phase 2
• High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate CancerActive, not recruitingNCT01655836Phase 1
• 99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404CompletedNCT01654874Phase 1
• Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its ProgressionActive, not recruitingNCT01653925Not applicable
• 3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate CancerActive, not recruitingNCT01653093Not applicable
• Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate CancerCompletedNCT01649635Phase 4
• A Study of Oral CFG920 in Patients With Castration Resistant Prostate CancerTerminatedNCT01647789Phase 1
• Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Pasireotide LAR in Patients With Castration Resistant Prostate CancerCompletedNCT01646684Phase 1
• Microspheres in Preventing Lymphatic Fluid Collection After Surgery in Patients With Prostate CancerTerminatedNCT01644136Not applicable
• Retrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at The JamesActive, not recruitingNCT01643954Not applicable
• Ion Prostate IrradiationCompletedNCT01641185Phase 2
• Evaluation of Modern MRI in the Diagnosis of Prostate Cancer in a Danish SetupCompletedNCT01640262
• Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer FociCompletedNCT01639859Not applicable
• Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionCompletedNCT01638533Phase 1
• Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) PatientsCompletedNCT01634061Phase 1
• Medical Economics of Urinary PCA3 Test for Prostate Cancer DiagnosisCompletedNCT01632930Not applicable
• Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Cancer (CRPC)WithdrawnNCT01630967Phase 2
• Daily Target Guided Radiation Therapy Using the Calypso 4D Localization System in Patients Who Have Had a Prostatectomy for Prostate CancerStatus unknownNCT01624623
• Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and ToxicityCompletedNCT01621425
• Safety Study of a Shorter (Hypofractionated) Radiotherapy for the Prostate Bed With or Without the Pelvic Lymph NodesCompletedNCT01620710Phase 2
• Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate CancerCompletedNCT01620515Phase 2
• Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate CancerCompletedNCT01619813Phase 2
• Phase II Study to Evaluate Conventional Radiation Therapy Followed by Radiosurgical Boost in Clinically Localized Prostate CancerStatus unknownNCT01618851Not applicable
• Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone MetastasesCompletedNCT01618370Phase 3
• Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate CancerWithdrawnNCT01617174
• Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate CancerActive, not recruitingNCT01617161Not applicable
• Detection of Micrometastases in Lymph Nodes of Patients With Prostate CancerStatus unknownNCT01615965Not applicable
• A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate CancerCompletedNCT01615406Phase 1
• Management of Prostate Cancer in Central ChinaCompletedNCT01614548
• Robotic Assisted Laparoscopic Prostatectomy With or Without Pelvic Drain Placement in Reducing Adverse Events After Surgery in Patients With Prostate CancerCompletedNCT01613651Phase 3
• Methylselenocysteine Effects on Circadian RhythmCompletedNCT01611038Not applicable
• A Phase I Study of LFA102 in Japanese PatientsCompletedNCT01610050Phase 1
• MRI for Assessing Prostate Cancer ResponseActive, not recruitingNCT01607008Not applicable
• Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyApproved for marketingNCT01606982
• 11C Acetate Imaging Post ProstatectomyTerminatedNCT01602783Not applicable
• Metabolic Effects of Treatment in Intermediate and High-Risk Prostate CancerCompletedNCT01599182
• Hypofractionated Stereotactic Boost in Prostate CancerCompletedNCT01596816Phase 2
• A Phase I/II Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)CompletedNCT01595087Phase 1/2
• Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate CancerCompletedNCT01594918Phase 1
• Acceptance-Based Treatment for Prostate Cancer DistressCompletedNCT01594593Not applicable
• Validation of Digital Morphometry for Cancer Risk in Benign Prostate BiopsiesCompletedNCT01594502
• Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate CancerCompletedNCT01591122Phase 3
• Radiotherapy vs Observation for CRPCStatus unknownNCT01590498
• Reduced Planning Target Volume (PTV) Margins for the Treatment of Prostate Cancer Using the Calypso 4D Localization SystemStatus unknownNCT01589939
• External Immobilization Compared to Limited Immobilization Using a Novel Real-time Localization System of the ProstateStatus unknownNCT01588938
• The Effect of Endurance Training in Patients With Prostate CancerCompletedNCT01584960Not applicable
• Prostate Advances in Comparative EvidenceActive, not recruitingNCT01584258Phase 3
• Focal Salvage HDR Brachytherapy for the Treatment of Prostate CancerActive, not recruitingNCT01583920Not applicable
• Evaluation of Truebeam for Low-Intermediate Risk Prostate CancerStatus unknownNCT01581749Phase 4
• Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate CancerCompletedNCT01578655Phase 3
• Oncological and Functional Outcomes After Radical Prostatectomy for Prostate Cancer: Comparing Open With Robot-assisted SurgeryCompletedNCT01578356
• Medico-economic Comparison of Robot-assisted Radical Prostatectomy Versus Radical Prostatectomy Via LaparotomyCompletedNCT01577836Not applicable
• Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate CancerCompletedNCT01576029Phase 2
• XL-184+Abiraterone in Post-Chemo CRPCCompletedNCT01574937Phase 1
• Prospective Multicentre Non-interventional Study of VANTAS® for the Treatment of Patients With Advanced Prostate CancerCompletedNCT01574846
• Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node DissectionCompletedNCT01572701Phase 1
• Prostate Hypoxia FAZACompletedNCT01567800Not applicable
• MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate CancerWithdrawnNCT01566045Not applicable
• Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics Study of BAY88-8223 in Japanese PatientsCompletedNCT01565746Phase 1
• Dorsal Penile Block for Post-Robotic Prostatectomy Foley DiscomfortWithdrawnNCT01565512Phase 1/2
• Evaluation of the Effect of Psycho-oncological Intervention on Well-being of Patients With Advanced Prostate Cancer on LHRH Analogs and Their Partners. A Randomized Controlled Pilot Study.TerminatedNCT01562522Phase 2
• Studying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate CancerStatus unknownNCT01562223Not applicable
• Study of Metformin With Simvastatin for Men With Prostate CarcinomaWithdrawnNCT01561482Phase 2
• Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant StateCompletedNCT01560858
• Online Study of Colorectal Cancer and Prostate Cancer Screening Decision MakingCompletedNCT01558583Not applicable
• Non-systemic Treatment for Patients With Low-volume Metastatic Prostate CancerCompletedNCT01558427Phase 2
• Second-line Chemotherapy in Castration Resistant Prostate CancerCompletedNCT01558219Phase 2
• Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation TherapyWithdrawnNCT01555632Not applicable
• Prospective Study to Compare a Limited Versus Extended Pelvic Lymphadenectomy During ProstatectomyStatus unknownNCT01555086Not applicable
• A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA ValuesCompletedNCT01553838Not applicable
• Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility StudyCompletedNCT01551576
• Curative Image Guided Radiotherapy for Prostate CancerActive, not recruitingNCT01550237Not applicable
• Phase 1 Trial of the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus Plus Radiation Therapy (RT) for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following ProstatectomyCompletedNCT01548807Phase 1
• The Effect of Combined General/Epidural Anesthesia Versus General Anesthesia on Diaphragmatic FunctionCompletedNCT01547416Phase 4
• A Phase II Study of Degarelix in the Management of Non-Metastatic Hormone-Refractory Prostate CancerTerminatedNCT01545882Phase 2
• The Use of Transperineal Ultrasound for Radiation Therapy Treatment Planning and Image Guidance in the Treatment of Prostate CancerCompletedNCT01545154
• Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate CancerCompletedNCT01543659Phase 1/2
• A Study Looking at Novel Scheduling of Cabazitaxel for Patients With Metastatic Prostate CancerCompletedNCT01541007Phase 2
• Prostate Cancer Prevention Trial With Quercetin and GenisteinStatus unknownNCT01538316Not applicable
• Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate CancersCompletedNCT01535898
• Ipilimumab and GMCSF Immunotherapy for Prostate CancerWithdrawnNCT01530984Phase 2
• Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate CancerStatus unknownNCT01530295Not applicable
• C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate AdenocarcinomaCompletedNCT01530269Phase 2
• For Cause Prostate Biopsy in REDUCE Population TrialCompletedNCT01529086
• Response of Patients on Surveillance for Prostate Cancer to DutasterideCompletedNCT01525914
• Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsCompletedNCT01522820Phase 1
• MR-guided Focused Ultrasound Treatment of Prostate Cancer: Focal Therapy for Locally Non-Advanced DiseaseCompletedNCT01522118Phase 1

← Prostatic Neoplasms overview